Track the Healius Limited stock price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Health Care sector, Healius Limited has published 14 reports. Market capitalisation: €315.9m. The latest transaction was filed on 28 August 2026 (Change in Substantial Holding). Among the most active insiders: its controlled bodies corporate listed in Annexure A. All data is free.
14
Insider Decl.
n/a
Thresholds
€12,203
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Healius Limited Hold (neutral), based on 10 analysts. Average price target: A$0.55.
19Σ signal
Buys €12,203n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,305 of 29,064 companies
43.9
score / 100
Value
52
Quality
36
FCF yld72%
Earn yld-49%
EV/EBITDA·
ROE-108%
Gross mgn84%
Net mgn-11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
22,978 shares@ A$0.87040.0059% mcap100.0% of flowShareASXISINISIN AU0000033359ASX:2924-03081721-2A1667897
14 of 14 declarations
Acerca de Healius Limited
Healius Limited es una empresa australiana especializada en servicios de salud y diagnóstico. Opera principalmente en la Bolsa de Valores de Australia (XASX).